RNC Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-19,605
| Closed | -$3.6M | – | 186 |
|
|
2021
Q2 | $3.6M | Buy |
19,605
+445
| +2% | +$81.8K | 0.19% | 75 |
|
|
2021
Q1 | $2.93M | Sell |
19,160
-2,759
| -13% | -$422K | 0.17% | 79 |
|
|
2020
Q4 | $3.43M | Buy |
21,919
+86
| +0.4% | +$13.4K | 0.21% | 74 |
|
|
2020
Q3 | $2.5M | Buy |
21,833
+430
| +2% | +$49.2K | 0.18% | 70 |
|
|
2020
Q2 | $2.4M | Sell |
21,403
-929
| -4% | -$104K | 0.17% | 69 |
|
|
2020
Q1 | $2.01M | Buy |
22,332
+190
| +0.9% | +$17.1K | 0.17% | 67 |
|
|
2019
Q4 | $2.4M | Buy |
22,142
+2,685
| +14% | +$290K | 0.15% | 76 |
|
|
2019
Q3 | $1.91M | Buy |
+19,457
| New | +$1.91M | 0.14% | 75 |
|